Status:

ENROLLING_BY_INVITATION

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy

Lead Sponsor:

Nanjing Medical University

Collaborating Sponsors:

Beijing Anzhen Hospital

Conditions:

Acute Aortic Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

Acute aortic syndrome (AAS) is a life-threatening condition. Inflammation plays a key role in the pathogenesis, development and progression of AAS, and is associated with significant mortality and mor...

Detailed Description

Aortopathy represent a major clinical challenge and are regarded as one of the leading causes of mortality among cardiovascular disorders. However, the pathological mechanisms underlying aortopathy ar...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Aged 18 years or older.
  • Patients with diagnosis of AAS, including aortic dissection, penetrating aortic ulcer or intramural hematoma.
  • Symptoms started within 14 days from surgery.
  • Patients received medical therapy, open surgical, endovascular, or hybrid repair.
  • Any other major cardiac surgical procedure concomitant with surgery for AAS, such as coronary artery bypass grafting or carotid artery replacement;
  • The patient or guardian agrees to participate in this study. Exclusion criteria
  • Patients aged \< 18 years.
  • Onset of symptoms \> 14 days from surgery.
  • AAS secondary to traumatic or iatrogenic injury.
  • Patients who declined participation in registration and follow-up investigation.

Exclusion

    Key Trial Info

    Start Date :

    January 1 2016

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2040

    Estimated Enrollment :

    10000 Patients enrolled

    Trial Details

    Trial ID

    NCT04398992

    Start Date

    January 1 2016

    End Date

    December 31 2040

    Last Update

    November 7 2024

    Active Locations (29)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 8 (29 locations)

    1

    Beijing Fuwai Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China

    2

    Chongqing Hospital of Jiangsu Provincial People's Hospital

    Chongqing, Chongqing Municipality, China

    3

    Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China

    4

    The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

    Additive Anti-inflammatory Action for Aortopathy & Arteriopathy | DecenTrialz